vs

Side-by-side financial comparison of Blue Bird Corp (BLBD) and Inspire Medical Systems, Inc. (INSP). Click either name above to swap in a different company.

Blue Bird Corp is the larger business by last-quarter revenue ($333.1M vs $269.1M, roughly 1.2× Inspire Medical Systems, Inc.). Inspire Medical Systems, Inc. runs the higher net margin — 50.6% vs 9.2%, a 41.3% gap on every dollar of revenue. On growth, Inspire Medical Systems, Inc. posted the faster year-over-year revenue change (12.2% vs 6.1%). Inspire Medical Systems, Inc. produced more free cash flow last quarter ($41.8M vs $31.1M). Over the past eight quarters, Inspire Medical Systems, Inc.'s revenue compounded faster (28.1% CAGR vs -1.9%).

The Blue Bird Corporation is an American bus manufacturer. Headquartered in Fort Valley, Georgia, the company was best known for its production of school buses. The company has also manufactured a wide variety of other bus types, including transit buses, motorhomes, and specialty vehicles such as mobile libraries and mobile police command centers.

Inspire Medical Systems, Inc. is a medical technology firm that develops, manufactures and commercializes implantable neurostimulation solutions for obstructive sleep apnea. Its core product serves patients intolerant to CPAP therapy, with main markets across North America, Europe, and select Asia-Pacific regions, operating in sleep medicine and otolaryngology segments.

BLBD vs INSP — Head-to-Head

Bigger by revenue
BLBD
BLBD
1.2× larger
BLBD
$333.1M
$269.1M
INSP
Growing faster (revenue YoY)
INSP
INSP
+6.1% gap
INSP
12.2%
6.1%
BLBD
Higher net margin
INSP
INSP
41.3% more per $
INSP
50.6%
9.2%
BLBD
More free cash flow
INSP
INSP
$10.7M more FCF
INSP
$41.8M
$31.1M
BLBD
Faster 2-yr revenue CAGR
INSP
INSP
Annualised
INSP
28.1%
-1.9%
BLBD

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BLBD
BLBD
INSP
INSP
Revenue
$333.1M
$269.1M
Net Profit
$30.8M
$136.1M
Gross Margin
21.4%
86.6%
Operating Margin
11.3%
17.1%
Net Margin
9.2%
50.6%
Revenue YoY
6.1%
12.2%
Net Profit YoY
7.1%
286.4%
EPS (diluted)
$0.94
$4.57

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLBD
BLBD
INSP
INSP
Q4 25
$333.1M
$269.1M
Q3 25
$409.4M
$224.5M
Q2 25
$398.0M
$217.1M
Q1 25
$358.9M
$201.3M
Q4 24
$313.9M
$239.7M
Q3 24
$350.2M
$203.2M
Q2 24
$333.4M
$195.9M
Q1 24
$345.9M
$164.0M
Net Profit
BLBD
BLBD
INSP
INSP
Q4 25
$30.8M
$136.1M
Q3 25
$36.5M
$9.9M
Q2 25
$36.5M
$-3.6M
Q1 25
$26.0M
$3.0M
Q4 24
$28.7M
$35.2M
Q3 24
$24.7M
$18.5M
Q2 24
$28.7M
$9.8M
Q1 24
$26.0M
$-10.0M
Gross Margin
BLBD
BLBD
INSP
INSP
Q4 25
21.4%
86.6%
Q3 25
21.1%
85.8%
Q2 25
21.6%
84.0%
Q1 25
19.7%
84.7%
Q4 24
19.2%
85.0%
Q3 24
17.0%
84.1%
Q2 24
20.8%
84.8%
Q1 24
18.4%
84.9%
Operating Margin
BLBD
BLBD
INSP
INSP
Q4 25
11.3%
17.1%
Q3 25
12.3%
4.3%
Q2 25
12.6%
-1.5%
Q1 25
9.4%
-0.7%
Q4 24
10.5%
13.3%
Q3 24
7.3%
7.0%
Q2 24
11.9%
2.6%
Q1 24
10.4%
-9.3%
Net Margin
BLBD
BLBD
INSP
INSP
Q4 25
9.2%
50.6%
Q3 25
8.9%
4.4%
Q2 25
9.2%
-1.7%
Q1 25
7.3%
1.5%
Q4 24
9.2%
14.7%
Q3 24
7.0%
9.1%
Q2 24
8.6%
5.0%
Q1 24
7.5%
-6.1%
EPS (diluted)
BLBD
BLBD
INSP
INSP
Q4 25
$0.94
$4.57
Q3 25
$1.11
$0.34
Q2 25
$1.12
$-0.12
Q1 25
$0.79
$0.10
Q4 24
$0.86
$1.17
Q3 24
$0.71
$0.60
Q2 24
$0.85
$0.32
Q1 24
$0.79
$-0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLBD
BLBD
INSP
INSP
Cash + ST InvestmentsLiquidity on hand
$241.7M
$308.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$271.4M
$781.2M
Total Assets
$642.3M
$907.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLBD
BLBD
INSP
INSP
Q4 25
$241.7M
$308.3M
Q3 25
$229.3M
$322.6M
Q2 25
$173.1M
$300.9M
Q1 25
$130.7M
$369.2M
Q4 24
$136.1M
$445.5M
Q3 24
$127.7M
$411.0M
Q2 24
$88.4M
$439.7M
Q1 24
$93.1M
$441.4M
Stockholders' Equity
BLBD
BLBD
INSP
INSP
Q4 25
$271.4M
$781.2M
Q3 25
$255.4M
$666.5M
Q2 25
$221.8M
$677.8M
Q1 25
$190.4M
$635.7M
Q4 24
$179.7M
$689.7M
Q3 24
$159.6M
$696.6M
Q2 24
$137.3M
$638.1M
Q1 24
$105.8M
$589.0M
Total Assets
BLBD
BLBD
INSP
INSP
Q4 25
$642.3M
$907.3M
Q3 25
$625.3M
$807.7M
Q2 25
$575.5M
$802.2M
Q1 25
$543.7M
$730.8M
Q4 24
$535.2M
$808.4M
Q3 24
$524.9M
$796.2M
Q2 24
$468.1M
$728.4M
Q1 24
$456.5M
$685.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLBD
BLBD
INSP
INSP
Operating Cash FlowLast quarter
$36.6M
$52.5M
Free Cash FlowOCF − Capex
$31.1M
$41.8M
FCF MarginFCF / Revenue
9.3%
15.5%
Capex IntensityCapex / Revenue
1.6%
4.0%
Cash ConversionOCF / Net Profit
1.19×
0.39×
TTM Free Cash FlowTrailing 4 quarters
$162.6M
$78.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLBD
BLBD
INSP
INSP
Q4 25
$36.6M
$52.5M
Q3 25
$65.1M
$68.5M
Q2 25
$56.9M
$2.7M
Q1 25
$27.8M
$-6.7M
Q4 24
$26.4M
$69.2M
Q3 24
$55.4M
$52.3M
Q2 24
$989.0K
$-78.0K
Q1 24
$54.6M
$8.9M
Free Cash Flow
BLBD
BLBD
INSP
INSP
Q4 25
$31.1M
$41.8M
Q3 25
$60.5M
$58.1M
Q2 25
$52.3M
$-6.3M
Q1 25
$18.7M
$-15.1M
Q4 24
$21.8M
$62.2M
Q3 24
$50.2M
$44.3M
Q2 24
$-3.5M
$-12.5M
Q1 24
$51.8M
$-2.8M
FCF Margin
BLBD
BLBD
INSP
INSP
Q4 25
9.3%
15.5%
Q3 25
14.8%
25.9%
Q2 25
13.1%
-2.9%
Q1 25
5.2%
-7.5%
Q4 24
7.0%
25.9%
Q3 24
14.3%
21.8%
Q2 24
-1.1%
-6.4%
Q1 24
15.0%
-1.7%
Capex Intensity
BLBD
BLBD
INSP
INSP
Q4 25
1.6%
4.0%
Q3 25
1.1%
4.6%
Q2 25
1.2%
4.1%
Q1 25
2.5%
4.2%
Q4 24
1.5%
2.9%
Q3 24
1.5%
3.9%
Q2 24
1.3%
6.3%
Q1 24
0.8%
7.1%
Cash Conversion
BLBD
BLBD
INSP
INSP
Q4 25
1.19×
0.39×
Q3 25
1.78×
6.90×
Q2 25
1.56×
Q1 25
1.07×
-2.24×
Q4 24
0.92×
1.96×
Q3 24
2.24×
2.83×
Q2 24
0.03×
-0.01×
Q1 24
2.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BLBD
BLBD

Alternative Fuel Buses$151.4M45%
Diesel Buses$144.9M43%
Parts$24.8M7%
Other$12.1M4%

INSP
INSP

Segment breakdown not available.

Related Comparisons